Skip to content

PHARMACIE COMPERE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARMACIE COMPERE

BE 0473.636.449
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€60,619
2024 · -€45,976-€14,643
Equity
€260,526
2024 · €321,977-€61,452
Cash
€36,335
2024 · €29,465+€6,870
Balance sheet total
€321,276
2024 · €398,563-€77,287

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€81,002

    down €81,002 (-33.3%), from €243,006 to €162,004

  • Stocks and contracts -€11,706

    down €11,706 (-18.0%), from €65,039 to €53,333

  • Cash +€6,870

    up €6,870 (+23.3%), from €29,465 to €36,335

    mainly Depreciation (+€82,566) and Stocks and contracts (+€11,706)

Equity and liabilities
  • Profit (loss) carried forward -€61,452

    down €61,452 (-19.6%), from €312,917 to €251,466

  • Short-term financial debts -€11,000

    no longer reported in 2025 (was €11,000)

  • Tax, wage and social debts -€7,438

    down €7,438 (-68.2%), from €10,907 to €3,469

    of which Taxes: -€8,439

  • Trade debts +€4,576

    up €4,576 (+8.9%), from €51,576 to €56,151

Income statement
  • Gross operating margin -€19,297

    down €19,297 (-30.0%), from €64,263 to €44,966

  • Taxes -€6,778

    down €6,778 (-52.3%), from €12,955 to €6,177

  • Staff costs +€6,381

    up €6,381 (+91.7%), from €6,960 to €13,342

  • Financial charges -€3,994

    down €3,994 (-71.1%), from €5,621 to €1,627

  • Other operating charges -€921

    down €921 (-32.3%), from €2,852 to €1,931

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€45,976
Gross operating margin -€19,297
Staff costs -€6,381
Depreciation -€174
Other operating charges +€921
Financial income -€485
Financial charges +€3,994
Taxes +€6,778
Result 2025 -€60,619
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€26,097
Investment -€5,362
Financing -€13,864
Cash 2024 €29,465
Net result for the year -€60,619
Depreciation +€82,566
Stocks and contracts +€11,706
Receivables within one year -€3,769
Deferred charges and accrued income -€983
Trade debts +€4,576
Tax, wage and social debts -€7,438
Other debts +€683
Accrued charges and deferred income -€625
Investment in fixed assets (net) -€5,362
Current portion of long-term debt -€2,031
Short-term financial debts -€11,000
Contributions, distributions and other -€833
Cash 2025 €36,335
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €398,563 €321,276 -€77,287 -19.4%
Fixed assets 21/28 €252,919 €175,715 -€77,204 -30.5%
Intangible fixed assets 21 €243,006 €162,004 -€81,002 -33.3%
Tangible fixed assets 22/27 €9,913 €13,711 +€3,798 +38.3%
Land and buildings 22 €3,718 €3,718 = 0.0%
Plant, machinery and equipment 23 €5,735 €9,340 +€3,605 +62.9%
Furniture and vehicles 24 €459 €652 +€193 +42.0%
Current assets 29/58 €145,645 €145,561 -€84 -0.1%
Stocks and contracts in progress 3 €65,039 €53,333 -€11,706 -18.0%
Stocks 30/36 €65,039 €53,333 -€11,706 -18.0%
Amounts receivable within one year 40/41 €50,151 €53,920 +€3,769 +7.5%
Trade receivables 40 €46,044 €47,248 +€1,204 +2.6%
Other amounts receivable 41 €4,106 €6,672 +€2,565 +62.5%
Cash at bank and in hand 54/58 €29,465 €36,335 +€6,870 +23.3%
Deferred charges and accrued income 490/1 €991 €1,974 +€983 +99.3%
Total equity and liabilities 10/49 €398,563 €321,276 -€77,287 -19.4%
Equity 10/15 €321,977 €260,526 -€61,452 -19.1%
Contributions 10/11 €7,200 €7,200 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Distributable reserves 133 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €312,917 €251,466 -€61,452 -19.6%
Amounts payable 17/49 €76,586 €60,750 -€15,836 -20.7%
Amounts payable within one year 42/48 €75,664 €60,454 -€15,210 -20.1%
Current portion of amounts payable after more than one year 42 €2,031 - -€2,031
Financial debts 43 €11,000 - -€11,000
Credit institutions 430/8 €11,000 - -€11,000
Trade debts 44 €51,576 €56,151 +€4,576 +8.9%
Suppliers 440/4 €51,576 €56,151 +€4,576 +8.9%
Taxes, remuneration and social security 45 €10,907 €3,469 -€7,438 -68.2%
Taxes 450/3 €10,876 €2,437 -€8,439 -77.6%
Remuneration and social security 454/9 €31 €1,032 +€1,001 +3,235%
Other amounts payable 47/48 €150 €833 +€683 +455%
Accrued charges and deferred income 492/3 €922 €297 -€625 -67.8%
Remuneration, social security and pensions 62 €6,960 €13,342 +€6,381 +91.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €82,393 €82,566 +€174 +0.2%
Other operating charges 640/8 €2,852 €1,931 -€921 -32.3%
Gross operating margin 9900 €64,263 €44,966 -€19,297 -30.0%
Operating profit (loss) 9901 -€27,943 -€52,873 -€24,930 -89.2%
Financial income 75/76B €543 €58 -€485 -89.2%
Recurring financial income 75 €543 €58 -€485 -89.2%
Financial charges 65/66B €5,621 €1,627 -€3,994 -71.1%
Recurring financial charges 65 €5,621 €1,627 -€3,994 -71.1%
Profit (loss) for the period before taxes 9903 -€33,021 -€54,442 -€21,421 -64.9%
Income taxes 67/77 €12,955 €6,177 -€6,778 -52.3%
Profit (loss) for the period 9904 -€45,976 -€60,619 -€14,643 -31.8%
Profit (loss) for the period to be appropriated 9905 -€45,976 -€60,619 -€14,643 -31.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.